Swedish pharma industry's ethical regulations updated

6 October 2025

On September 29, a number of changes to LER – the pharmaceutical industry’s ethical regulations – came into effect. “The changes are small but necessary for the rules to be effective and meet new regulations,” says Mikaela Karlsson Larsen, compliance officer at Swedish pharma trade group, Lif.

LER is part of the pharmaceutical industry's own action system, which is intended to maintain high ethics and strong trust in companies. It contains regulations for how medicines may be marketed and regulates collaboration with stakeholders such as healthcare professionals and interest organizations.

LER is continuously updated to keep up with developments and remain useful and relevant. A new version will be in effect from September 29th.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK